Carvacrol Essential Oil: A Natural Antibiotic against Zoonotic Multidrug-Resistant <i>Staphylococcus</i> Species Isolated from Diseased Livestock and Humans
<i>Staphylococcus</i> species cause diseases in animals and humans. The prevalence and antimicrobial profiles of <i>Staphylococcus</i> spp. in animals and human samples in the Minya Governorate, Egypt, were determined, and resistance- and virulence-associated genes were obser...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_a9313ed95ee645c09e2cf2744f9b81d5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Ahmed H. Abed |e author |
700 | 1 | 0 | |a Esraa F. Hegazy |e author |
700 | 1 | 0 | |a Sherif A. Omar |e author |
700 | 1 | 0 | |a Rehab M. Abd El-Baky |e author |
700 | 1 | 0 | |a Ahmed A. El-Beih |e author |
700 | 1 | 0 | |a Ahmed Al-Emam |e author |
700 | 1 | 0 | |a Ahmed M. S. Menshawy |e author |
700 | 1 | 0 | |a Eman Khalifa |e author |
245 | 0 | 0 | |a Carvacrol Essential Oil: A Natural Antibiotic against Zoonotic Multidrug-Resistant <i>Staphylococcus</i> Species Isolated from Diseased Livestock and Humans |
260 | |b MDPI AG, |c 2021-10-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics10111328 | ||
500 | |a 2079-6382 | ||
520 | |a <i>Staphylococcus</i> species cause diseases in animals and humans. The prevalence and antimicrobial profiles of <i>Staphylococcus</i> spp. in animals and human samples in the Minya Governorate, Egypt, were determined, and resistance- and virulence-associated genes were observed in multidrug-resistant (MDR) isolates. Moreover, the antibacterial effect of carvacrol essential oil (EO) on the MDR isolates was studied. A total of 216 samples were aseptically collected from subclinically mastitic cow's milk (<i>n</i> = 100), sheep abscesses (<i>n</i> = 25) and humans (<i>n</i> = 91). Out of 216 samples, a total of 154 single <i>Staphylococcus</i> species (71.3%) were isolated. The most frequent bacterial isolates were <i>S. aureus</i> (43%), followed by <i>S. schleiferi</i> (25%), <i>S. intermedius</i> (12%), <i>S. xylosus</i> (12%), <i>S. haemolyticus</i> (4.5%), S. <i>epidermidis</i> (2%) and <i>S. aurecularis</i> (1%). Haemolytic activity and biofilm production were detected in 77 and 47% of isolates, respectively. Antimicrobial susceptibility testing showed a high degree of resistance to the most commonly used antimicrobials in human and veterinary practices. The <i>mec</i>A, <i>van</i>A, <i>van</i>C1 and <i>erm</i>C resistance genes were detected in 93, 42, 83 and 13% of isolates, respectively. Moreover, <i>hla</i>, <i>ica</i>A and <i>ica</i>D virulence genes were detected in 50, 75 and 78% of isolates, respectively. Carvacrol effectively inhibited the growth of all tested isolates at concentrations of 0.1, 0.05 and 0.04% while a concentration of 0.03% inhibited 75% of isolates. Interestingly, some phenotypic changes were observed upon treatment with a carvacrol oil concentration of 0.03%. All the treated MDR <i>Staphylococcus</i> isolates changed from multidrug resistant to either susceptible or intermediately susceptible to 2-3 antimicrobials more than parental bacterial isolates. Real-time PCR was applied for the detection of the differential expression of <i>mec</i>A and <i>van</i>C1 genes before and after treatment with carvacrol which revealed a mild reduction in both genes' expression after treatment. <i>Staphylococcus</i> spp. Containing MDR genes are more likely to spread between humans and animals. From these results, carvacrol EO is a promising natural alternative to conventional antimicrobials for pathogens impacting human health and agriculture due to its potential antimicrobial effect on MDR pathogens; even in sub-lethal doses, carvacrol EO can affect their phenotypic properties and genes' expression. | ||
546 | |a EN | ||
690 | |a <i>Staphylococci</i> | ||
690 | |a <i>S. aureus</i> | ||
690 | |a antimicrobial resistance | ||
690 | |a MRSA | ||
690 | |a VRSA | ||
690 | |a haemolysis | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 10, Iss 11, p 1328 (2021) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/10/11/1328 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/a9313ed95ee645c09e2cf2744f9b81d5 |z Connect to this object online. |